Hepatectomy Clinical Trials

Clinical trials related to Hepatectomy Procedure

ICG Anastomotic Control in Digestive System Surgery

Status: Unknown
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY

This was a parallel single-center retrospective cohort study conducted at Linglong Yingcheng Hospital, Shandong, China. The purpose of this study was to investigate the effect of indocyanine green (ICG) on patients undergoing digestive system surgery (subtotal gastrectomy, partial hepatectomy, transverse colectomy, left colectomy, including sigmoid resection, and splenic colic resection). ) of anastomotic leakage (AL). Secondary objectives were to detect and study the impact of various risk factors on AL and on morbidity and surgical performance within 30 days of surgery.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: f
View:

• elective setting of surgery

• digestive system surgery for benign or malignant pathology

• 30 days of post-operative follow-up at least available from medical documentation

• primary colo-colic or colo-rectal anastomosis with or without preventing ostomy

• more than 18 years old, less than 90 years old

Locations
Other Locations
China
Shandong Linglong Yingcheng Hospital
RECRUITING
Yantai
Contact Information
Primary
Xuan Qiu, MD
qiuxuan100@163.com
8618354280081
Backup
Ni Wang, MD,PD
wangni1989@163.com
8618705353551
Time Frame
Start Date: 2018-01-01
Completion Date: 2024-06-01
Participants
Target number of participants: 200
Treatments
Indocyanine Green
Indocyanine green infusion during digestive system surgery
non-Indocyanine Green
No indocyanine green infusion during digestive system surgery
Related Therapeutic Areas
Sponsors
Leads: Shandong Linglong Yingcheng Hospital

This content was sourced from clinicaltrials.gov